Integrative molecular analysis of metastatic Merkel cell carcinoma to identify predictive biomarkers of response to avelumab.

被引：1
|
作者：
Georges, Sara
Shah, Parantu K.
Shapiro, Irina
Hicking, Christine
Lu, Lei
Hennessy, Meliessa
D'Angelo, Sandra P.
Cai, Ti
机构：
[1] EMD Serono Res & Dev Inc, Global Dev, Billerica, MA USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.9569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9569
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Severe Demyelinating Polyneuropathy and Cranial Neuropathy During Avelumab Treatment of Metastatic Merkel Cell Carcinoma
    Bilic, Hrvoje
    Sitas, Barbara
    Hancevic, Mirea
    Habek, Mario
    Simetic, Luka
    Bilic, Ervina
    CLINICAL NEUROPHARMACOLOGY, 2021, 44 (05) : 193 - 195
  • [42] Exploratory biomarker analysis in avelumab-treated patients with metastatic Merkel cell carcinoma progressed after chemotherapy.
    Shapiro, Irina
    Grote, Hans Juergen
    D'Urso, Vittorio
    von Heydebreck, Anja
    Mahnke, Lisa
    Kaufman, Howard
    Nghiem, Paul
    Cal, Ti
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] COST-EFFECTIVENES ANALYSIS OF AVELUMAB AS SECOND-LINE TREATMENT FOR PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA IN RUSSIA
    Avxentyev, N. A.
    Frolov, M.
    Makarov, A.
    Palencia, R.
    Kudelya, O., V
    Kovaleva, E. R.
    VALUE IN HEALTH, 2019, 22 : S511 - S511
  • [44] Complete response to avelumab in Merkel Cell Carcinoma, and potential correlation with toxicity: a case report
    Femia, D.
    Prinzi, N.
    Pusceddu, S.
    Concas, L.
    Lo Russo, G.
    Claudio, V.
    Milione, M.
    Dinoi, G.
    Raimondi, A.
    Michele, P.
    Filippo, D. B.
    Buzzoni, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [45] Integrative molecular analysis of metastatic hepatocellular carcinoma
    Dongfang Wang
    Yanjing Zhu
    Jing Tang
    Qiuyu Lian
    Guijuan Luo
    Wen Wen
    Michael Q. Zhang
    Hongyang Wang
    Lei Chen
    Jin Gu
    BMC Medical Genomics, 12
  • [46] Integrative molecular analysis of metastatic hepatocellular carcinoma
    Wang, Dongfang
    Zhu, Yanjing
    Tang, Jing
    Lian, Qiuyu
    Luo, Guijuan
    Wen, Wen
    Zhang, Michael Q.
    Wang, Hongyang
    Chen, Lei
    Gu, Jin
    BMC MEDICAL GENOMICS, 2019, 12 (01)
  • [47] An Updated Review of the Biomarkers of Response to Immune Checkpoint Inhibitors in Merkel Cell Carcinoma: Merkel Cell Carcinoma and Immunotherapy
    Fojnica, Adnan
    Ljuca, Kenana
    Akhtar, Saghir
    Gatalica, Zoran
    Vranic, Semir
    CANCERS, 2023, 15 (20)
  • [48] Biomarker Analyses Investigating Disease Biology and Associations with Outcomes in the JAVELIN Merkel 200 Trial of Avelumab in Metastatic Merkel Cell Carcinoma
    D'Angelo, Sandra P.
    Lebbe, Celeste
    Nghiem, Paul
    Brohl, Andrew S.
    Mrowiec, Thomas
    Leslie, Trent
    Georges, Sara
    Guzel, Gulseren
    Shah, Parantu
    CLINICAL CANCER RESEARCH, 2024, 30 (19) : 4352 - 4362
  • [49] Prognostic and predictive biomarkers for metastatic renal cell carcinoma
    Briggs, Logan G.
    Cone, Eugene B.
    Lee, Richard J.
    Blute, Michael L.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7
  • [50] Integrative transcriptional analysis to identify predictive biomarkers for IBD severity and subtyping
    Balasubramanian, B.
    Patel, S.
    Gall, L.
    Parker, S.
    Carpenter, A.
    Hannan, N.
    Pin, C.
    Moran, G.
    Moran, P. Ordonez
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I460 - I460
12345